SRXH — SRx Health Solutions Cashflow Statement
0.000.00%
Last trade - 00:00- $13.40m
- $16.55m
- $6.53m
Annual cashflow statement for SRx Health Solutions, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 3.39 | -39.3 | -22.8 | -0.168 | -8.64 |
| Depreciation | |||||
| Non-Cash Items | -15.1 | 25.7 | 10.8 | -4.75 | 0.133 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.85 | -8.6 | 10.4 | 0.426 | -8.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.9 | -20.6 | 0.097 | -4.36 | -16.7 |
| Capital Expenditures | -0.353 | -0.198 | -0.018 | -0.041 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -2.21 | 5.91 |
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.353 | -0.198 | -0.018 | -2.25 | 5.91 |
| Financing Cash Flow Items | 35.9 | -0.11 | -0.244 | — | -0.154 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 37.2 | 1.28 | -5.1 | 5.22 | 12.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 25 | -19.5 | -5.02 | -1.39 | 1.2 |